A candidate gene approach to searching for low-penetrance breast and prostate cancer genes

被引：143

作者：

Hunter, DJ ^{[1
]}

Riboli, E ^{[1
]}

Haiman, CA ^{[1
]}

Albanes, D ^{[1
]}

Altshuler, D ^{[1
]}

Chanock, SJ ^{[1
]}

Hayes, RB ^{[1
]}

Henderson, BE ^{[1
]}

Kaaks, R ^{[1
]}

Stram, DO ^{[1
]}

Thomas, G ^{[1
]}

Thun, MJ ^{[1
]}

机构：

[1] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA

来源：

NATURE REVIEWS CANCER | 2005年 / 5卷 / 12期

关键词：

D O I：

10.1038/nrc1754

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Most cases of breast and prostate cancer are not associated with mutations in known high-penetrance genes, indicating the involvement of multiple low-penetrance risk alleles. Studies that have attempted to identify these genes have met with limited success. The National Cancer Institute Breast and Prostate Cancer Cohort Consortium - a pooled analysis of multiple large cohort studies with a total of more than 5,000 cases of breast cancer and 8,000 cases of prostate cancer - was therefore initiated. The goal of this consortium is to characterize variations in approximately 50 genes that mediate two pathways that are associated with these cancers - the steroid-hormone metabolism pathway and the insulin-like growth factor signalling pathway - and to associate these variations with cancer risk.

引用

页码：977 / 985

页数：9

共 97 条

[31]

Hall K., 1999, Journal of Endocrinological Investigation, V22, P48

[32] Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis [J].

Halushka, MK ;

Fan, JB ;

Bentley, K ;

Hsie, L ;

Shen, NP ;

Weder, A ;

Cooper, R ;

Lipshutz, R ;

Chakravarti, A .

NATURE GENETICS, 1999, 22 (03) :239-247

[33] Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women [J].

Hankinson, SE ;

Willett, WC ;

Manson, JE ;

Colditz, GA ;

Hunter, DJ ;

Spiegelman, D ;

Barbieri, RL ;

Speizer, FE .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (17) :1292-1299

[34] Circulating concentrations of insulin-like growth factor-I and risk of breast cancer [J].

Hankinson, SE ;

Willett, WC ;

Colditz, GA ;

Hunter, DJ ;

Michaud, DS ;

Deroo, B ;

Rosner, B ;

Speizer, FE ;

Pollak, M .

LANCET, 1998, 351 (9113) :1393-1396

[35] Genetic perspectives on human origins and differentiation [J].

Harpending, H ;

Rogers, A .

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2000, 1 :361-385

[36] Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3 [J].

Harrela, M ;

Koistinen, H ;

Kaprio, J ;

Lehtovirta, M ;

Tuomilehto, J ;

Eriksson, J ;

Tolvanen, L ;

Koskenvuo, M ;

Leinonen, P ;

Koistinen, R ;

Seppala, M .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11) :2612-2615

[37] Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial [J].

Hayes, RB ;

Reding, D ;

Kopp, W ;

Subar, AF ;

Bhat, N ;

Rothman, N ;

Caporaso, N ;

Ziegler, RG ;

Johnson, CC ;

Weissfeld, JL ;

Hoover, RN ;

Hartge, P ;

Palace, C ;

Gohagan, JK .

CONTROLLED CLINICAL TRIALS, 2000, 21 (06) :349S-355S

[38] Hormonal carcinogenesis [J].

Henderson, BE ;

Feigelson, HS .

CARCINOGENESIS, 2000, 21 (03) :427-433

[39] Associations between insulin-like growth factor-I (IGF-I), IGF-binding protein-1, insulin and other metabolic measures after controlling for genetic influences: Results from middle-aged and elderly monozygotic twins [J].

Hong, Y ;

Brismar, K ;

Hall, K ;

Pedersen, NL ;

deFaire, U .

JOURNAL OF ENDOCRINOLOGY, 1997, 153 (02) :251-257

[40]

Jefcoate C R, 2000, J Natl Cancer Inst Monogr, P95

← 1 2 3 4 5 6 7 8 9 10 →